针对结核病治疗的新型 purin 生物合成
Dirk A Lamprecht1,2, Richard J Wall3, Annelies Leemans4
1Janssen Global Public Health, LLC, Janssen Pharmaceutica NV, Antwerp, Belgium. dirk.lamprecht@uct.ac.za.
Nature
|June 18, 2025
概括
一种新的候选药物,JNJ-6640,有效地抑制PurF,这是一种对结核病细菌生存至关重要的酶. 这一发现为抗药结核病提供了一种新的策略.
科学领域:
- 微生物学
- 药物发现
- 生物化学
背景情况:
- 结核病是全球主要的传染病死亡原因.
- 现有的治疗方法面临抗药性菌株的挑战.
- 迫切需要新的治疗目标来控制结核病.
研究的目的:
- 发现和描述一种针对Mycobacterium新型 purin生物合成途径的新型小分子抑制剂.
- 评估化合物JNJ-6640对结核的疗效和特异性.
- 探索针对de novo purin生物合成作为结核病治疗的新策略的潜力.
主要方法:
- 针对PurF的小分子抑制剂的鉴定和表征,PurF是菌根新生生物合成的初始酶.
- 在体外测试以确定对真菌菌菌的杀菌活性和特异性.
- 用单细胞显微镜观察细菌过程的下游影响,比如DNA复制.
- 在人类和小鼠肺组织中测量核基度.
- 使用长效注射剂的体内疗效研究.
主要成果:
- 化合物JNJ-6640在体外显示出纳米杀菌活性.
- 通过遗传和生化方法证实,JNJ-6640对菌根PurF具有高选择性.
- 肺组织中生理相关的核基度不足以克服PurF抑制.
- 概念验证研究证实了JNJ-6640通过长效注射配方的体内疗效.
- JNJ-6640对DNA复制产生了下游影响.
结论:
- JNJ-6640是一种有前途的第一类抑制剂,向菌根PurF.
- 针对新的纯素生物合成是开发新的结核病药物的可行和新策略.
- JNJ-6640有可能改善耐药结核病的治疗方案.
相关概念视频
Pulmonary Tuberculosis V
249
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
249
Biosynthesis of Nucleic Acids
204
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
204
Pulmonary Tuberculosis IV
209
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
209
Pulmonary Tuberculosis I
335
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
335
Pulmonary Tuberculosis II
387
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
387
Pulmonary Tuberculosis III
458
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
458


